+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transcatheter Pulmonary Valve Market by Product Type, Valve Material, Delivery System, Disease Type, Technology Integration, End User - Global Forecast 2026-2032- Product Image
Transcatheter Pulmonary Valve Market by Product Type, Valve Material, Delivery System, Disease Type, Technology Integration, End User - Global Forecast 2026-2032- Product Image
Sale

Transcatheter Pulmonary Valve Market by Product Type, Valve Material, Delivery System, Disease Type, Technology Integration, End User - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4985967
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Transcatheter Pulmonary Valve Market is projected to reach USD 97.55 Million in 2026. It is expected to continue growing at a CAGR of 5.29%, reaching USD 133.15 Million by 2032.

Transcatheter pulmonary valve replacement is a specialized structural heart intervention used to treat right ventricular outflow tract dysfunction, most often in patients with repaired congenital heart disease, including tetralogy of Fallot, pulmonary atresia, or prior conduit repair. By restoring pulmonary valve competence without repeat open-heart surgery, transcatheter pulmonary valve technologies support a lifelong care pathway in which many patients require multiple reinterventions across pediatric, adolescent, and adult stages of care.

The market is supported by a clinically established evidence base, including long-term follow-up for early transcatheter pulmonary valve systems and expanding use of balloon-expandable and self-expanding platforms for selected anatomies. Demand is closely tied to congenital heart disease surveillance, cardiac MRI and CT-based sizing, pediatric-to-adult transition programs, multidisciplinary heart teams, and the availability of experienced congenital interventional cardiology centers.

Transformative Shifts in the Transcatheter Pulmonary Valve Landscape

The transcatheter pulmonary valve landscape is shifting from conduit-only treatment toward broader anatomical coverage, including native and surgically repaired right ventricular outflow tracts. This change is clinically significant because many repaired tetralogy of Fallot patients have enlarged, non-cylindrical outflow tracts that historically limited transcatheter eligibility and increased reliance on repeat surgical pulmonary valve replacement.

Clinical practice is also moving toward lifetime valve management rather than single-episode intervention. Operators increasingly consider staged prestenting, valve-in-valve planning, coronary compression testing, endocarditis risk mitigation, radiation reduction, and future reaccess when selecting a device. As adult congenital heart disease populations grow due to improved survival, hospitals with combined pediatric and adult structural heart capabilities are better positioned to manage referrals, imaging, intervention, and long-term surveillance.

Cumulative Impact of Artificial Intelligence on TPV Care

Artificial intelligence is beginning to influence transcatheter pulmonary valve care through imaging automation, anatomy classification, device sizing support, and post-procedure surveillance. AI-enabled segmentation of CT and cardiac MRI can help quantify right ventricular volumes, pulmonary regurgitation severity, conduit dimensions, calcification, landing-zone geometry, and spatial relationships with the coronary arteries, which are variables that directly shape procedural feasibility and patient selection.

The near-term impact is expected to be cumulative rather than disruptive. AI tools can reduce planning time, improve measurement reproducibility, support longitudinal monitoring, and help standardize multidisciplinary review, but clinical decisions still require physician oversight, validated algorithms, transparent performance data, and regulatory clearance where applicable. The strongest commercial value will come from integrating AI into workflow platforms that connect congenital cardiology, radiology, catheterization laboratories, surgical teams, and longitudinal follow-up programs.

Key Regional Insights for Transcatheter Pulmonary Valve Adoption

North America remains a leading region for transcatheter pulmonary valve adoption due to cleared device availability, mature adult congenital heart disease programs, established structural heart infrastructure, and high utilization of advanced imaging. The United States drives most regional procedure activity through specialized congenital and structural heart centers, while Canada benefits from centralized congenital cardiac networks, provincial care pathways, and public-sector reimbursement mechanisms that support access in selected referral hospitals.

Europe shows broad clinical expertise across the United Kingdom, Germany, France, Italy, and Spain, supported by congenital heart disease guidelines, national referral networks, and experienced tertiary centers. The European regulatory environment has increased evidence, clinical evaluation, and post-market surveillance expectations for medical devices, which can lengthen commercialization timelines but strengthens quality, traceability, and safety standards for transcatheter pulmonary valve technologies.

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in congenital heart services, cardiac imaging, and structural heart capabilities. Latin America, led by Brazil and Mexico, is growing selectively through private hospitals, academic centers, and national reference institutions. The Middle East, particularly high-income Gulf states, is building high-acuity cardiac programs and cross-border referral capacity, while Africa remains constrained by limited congenital catheterization infrastructure, workforce shortages, and delayed diagnosis, despite clear long-term clinical need for less invasive pulmonary valve reintervention.

Key Group Insights Across G7, EU, BRICS, ASEAN, GCC, and NATO

Among economic and political groups, the G7 represents the most mature base for transcatheter pulmonary valve demand because it combines advanced congenital care, established reimbursement frameworks, strong imaging infrastructure, specialized catheterization laboratories, and earlier access to approved technologies. NATO membership overlaps with many high-income markets in North America and Europe, reinforcing clinical collaboration, procurement stability, physician exchange, and standardized cardiovascular care practices across several leading transcatheter pulmonary valve adoption environments.

The European Union is strategically important because harmonized regulatory oversight shapes evidence expectations for manufacturers seeking broader European access and emphasizes post-market clinical follow-up, device traceability, and safety monitoring. BRICS countries offer scale, especially through China, India, and Brazil, but access varies by reimbursement coverage, specialist availability, domestic procurement priorities, and import pathways. ASEAN markets are earlier in adoption, with more developed cardiac programs in countries such as Singapore, Thailand, and Malaysia serving as regional reference points. GCC countries are investing in tertiary cardiovascular centers, medical tourism, and high-acuity care capacity, creating opportunities for premium structural heart technologies when clinical training, reimbursement alignment, and referral networks are in place.

Key Country Insights for Transcatheter Pulmonary Valve Growth

The United States is the most influential country environment for transcatheter pulmonary valve adoption, supported by regulatory clearances, pediatric and adult congenital heart programs, advanced imaging capacity, and strong structural heart ecosystems. Canada follows through coordinated provincial systems and specialized congenital centers that concentrate expertise. Mexico and Brazil show rising demand for less invasive congenital heart reintervention, but access remains more dependent on hospital budgets, private insurance coverage, public procurement cycles, and the concentration of trained interventional cardiologists.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine guideline-driven congenital heart care with leading tertiary centers and established multidisciplinary decision-making. Germany is particularly relevant for procedural capacity, health technology evaluation, and advanced hospital infrastructure, while the United Kingdom and France benefit from organized specialist networks. Italy and Spain maintain strong congenital cardiology expertise, although regional reimbursement and hospital access may influence adoption pace. Russia has meaningful clinical need but faces variability in access linked to procurement complexity, referral geography, and geopolitical constraints affecting device availability.

China and India are high-potential markets due to large congenital heart disease populations, improving diagnosis, and expanding tertiary cardiac care, but adoption depends on affordability, reimbursement development, approved device access, and trained operators. Japan, South Korea, and Australia have advanced imaging, rigorous clinical standards, and tertiary cardiac care systems that support quality-driven uptake where approved devices and reimbursement pathways are available. Across these countries, durable outcomes, anatomical fit, operator training, and long-term surveillance remain central to adoption.

Actionable Recommendations for Transcatheter Pulmonary Valve Leaders

Industry leaders should prioritize anatomical breadth, durable valve performance, and ease of implantation. Products that address large native right ventricular outflow tracts, reduce paravalvular leak, minimize stent fracture risk, support accurate positioning, and preserve future intervention options are positioned to meet the most important clinical needs in transcatheter pulmonary valve replacement.

Commercial strategy should focus on centers of excellence, congenital heart disease registries, physician education, proctoring, imaging-based planning, and evidence generation in real-world cohorts. Manufacturers and technology developers should invest in AI-enabled imaging partnerships, procedural simulation, operator training, patient follow-up systems, and post-market surveillance while aligning market access strategies with local reimbursement, regulatory, and health technology assessment requirements.

Research Methodology for TPV Market Intelligence

This executive summary is based on secondary research, clinical literature review, regulatory intelligence, and market triangulation across device approvals, congenital heart disease guidelines, hospital capabilities, imaging adoption, and regional reimbursement dynamics. Sources considered include peer-reviewed cardiology publications, public regulatory information, professional society guidance, clinical trial records, hospital capability indicators, and publicly available medical technology disclosures without relying on speculative sizing or forecasting.

Insights were validated through cross-comparison of clinical adoption drivers, procedure eligibility criteria, anatomical requirements, regional infrastructure, access conditions, and competitive technology trends. The methodology emphasizes verified evidence over market estimation and highlights practical indicators such as approved indications, long-term safety evidence, specialist availability, imaging infrastructure, reimbursement readiness, and post-market surveillance obligations.

Conclusion: Outlook for the Transcatheter Pulmonary Valve Market

The transcatheter pulmonary valve market is advancing from a niche congenital intervention toward a broader lifetime management segment within structural heart care. Adoption is supported by expanding adult congenital heart disease populations, improved cardiac MRI and CT planning, wider anatomical eligibility, growing valve-in-valve experience, and increasing preference for less invasive reintervention when clinically appropriate.

Sustainable leadership will depend on clinical evidence, device versatility, operator training, regional access planning, and digital workflow integration. Stakeholders that combine robust valve platforms with imaging intelligence, registry participation, post-market data, and multidisciplinary care support will be best positioned to create value in this specialized and strategically important cardiovascular field.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Transcatheter Pulmonary Valve Market, by Product Type
7.1. Balloon-Expandable Valves
7.2. Self-Expanding Valves
7.3. Advanced Valve Systems
8. Transcatheter Pulmonary Valve Market, by Valve Material
8.1. Biological (Tissue) Valve
8.2. Synthetic / Polymer Valves
9. Transcatheter Pulmonary Valve Market, by Delivery System
9.1. Transvenous Approach
9.2. Transjugular Approach
9.3. Hybrid Surgical-Transcatheter Approach
10. Transcatheter Pulmonary Valve Market, by Disease Type
10.1. Pulmonary Valve Stenosis
10.2. Pulmonary Valve Regurgitation
10.3. Right Ventricular Outflow Tract (RVOT) Dysfunction
10.4. Congenital Heart Diseases
11. Transcatheter Pulmonary Valve Market, by Technology Integration
11.1. Imaging-Guided Systems
11.2. AI & Navigation Integration
12. Transcatheter Pulmonary Valve Market, by End User
12.1. Hospitals
12.2. Ambulatory Surgical Centers
12.3. Specialty Cardiac Centers
13. Asia-Pacific Transcatheter Pulmonary Valve Market
14. Europe Transcatheter Pulmonary Valve Market
15. North America Transcatheter Pulmonary Valve Market
16. Latin America Transcatheter Pulmonary Valve Market
17. Africa Transcatheter Pulmonary Valve Market
18. Middle East Transcatheter Pulmonary Valve Market
19. NATO Transcatheter Pulmonary Valve Market
20. G7 Transcatheter Pulmonary Valve Market
21. BRICS Transcatheter Pulmonary Valve Market
22. European Union Transcatheter Pulmonary Valve Market
23. ASEAN Transcatheter Pulmonary Valve Market
24. GCC Transcatheter Pulmonary Valve Market
25. China Transcatheter Pulmonary Valve Market
26. United States Transcatheter Pulmonary Valve Market
27. Japan Transcatheter Pulmonary Valve Market
28. India Transcatheter Pulmonary Valve Market
29. Germany Transcatheter Pulmonary Valve Market
30. United Kingdom Transcatheter Pulmonary Valve Market
31. Australia Transcatheter Pulmonary Valve Market
32. France Transcatheter Pulmonary Valve Market
33. South Korea Transcatheter Pulmonary Valve Market
34. Italy Transcatheter Pulmonary Valve Market
35. Canada Transcatheter Pulmonary Valve Market
36. Russia Transcatheter Pulmonary Valve Market
37. Brazil Transcatheter Pulmonary Valve Market
38. Mexico Transcatheter Pulmonary Valve Market
39. Spain Transcatheter Pulmonary Valve Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. Abbott Laboratories
41.2. Artivion Inc.
41.3. Boston Scientific Corporation
41.4. Braile Biomedica
41.5. Edwards Lifesciences Corporation
41.6. Lepu Medical Technology
41.7. LivaNova PLC
41.8. Med-Zenith
41.9. Medtronic plc
41.10. Meril Life Sciences Pvt. Ltd.
41.11. MicroPort Scientific Corporation
41.12. OrbusNeich Medical Group
41.13. PolyVascular Inc.
41.14. Taewoong Medical
41.15. Terumo Corporation
41.16. Venus Medtech (Hangzhou) Inc.
41.17. Xeltis AG
List of Figures
FIGURE 1. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2025 VS 2032 (%)
FIGURE 19. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
FIGURE 21. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 25. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BALLOON-EXPANDABLE VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BALLOON-EXPANDABLE VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BALLOON-EXPANDABLE VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SELF-EXPANDING VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SELF-EXPANDING VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SELF-EXPANDING VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ADVANCED VALVE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ADVANCED VALVE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ADVANCED VALVE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICAL (TISSUE) VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICAL (TISSUE) VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICAL (TISSUE) VALVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SYNTHETIC / POLYMER VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SYNTHETIC / POLYMER VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SYNTHETIC / POLYMER VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL TRANSVENOUS APPROACH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL TRANSVENOUS APPROACH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL TRANSVENOUS APPROACH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL TRANSJUGULAR APPROACH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL TRANSJUGULAR APPROACH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL TRANSJUGULAR APPROACH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HYBRID SURGICAL-TRANSCATHETER APPROACH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HYBRID SURGICAL-TRANSCATHETER APPROACH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HYBRID SURGICAL-TRANSCATHETER APPROACH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PULMONARY VALVE STENOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PULMONARY VALVE STENOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PULMONARY VALVE STENOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PULMONARY VALVE REGURGITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PULMONARY VALVE REGURGITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PULMONARY VALVE REGURGITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL RIGHT VENTRICULAR OUTFLOW TRACT (RVOT) DYSFUNCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL RIGHT VENTRICULAR OUTFLOW TRACT (RVOT) DYSFUNCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL RIGHT VENTRICULAR OUTFLOW TRACT (RVOT) DYSFUNCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CONGENITAL HEART DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CONGENITAL HEART DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CONGENITAL HEART DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL IMAGING-GUIDED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL IMAGING-GUIDED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL IMAGING-GUIDED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL AI & NAVIGATION INTEGRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL AI & NAVIGATION INTEGRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL AI & NAVIGATION INTEGRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 67. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 68. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 69. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 70. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 71. ASIA-PACIFIC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 72. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 74. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 75. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 76. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 77. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 78. EUROPE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 93. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 95. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 96. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 97. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 98. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 99. AFRICA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 103. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 106. MIDDLE EAST TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 110. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 111. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 112. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 113. NATO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 117. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 118. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 119. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 120. G7 TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 123. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 124. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 125. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 126. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 127. BRICS TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 130. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 131. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 132. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 133. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 134. EUROPEAN UNION TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 137. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 138. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 139. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 140. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 141. ASEAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 144. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 145. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 146. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 147. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 148. GCC TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 150. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 151. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 152. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 153. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 154. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 155. CHINA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 157. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 158. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 159. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 160. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 161. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 162. UNITED STATES TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 164. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 166. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 167. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 168. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 169. JAPAN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 171. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 172. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 173. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 174. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 175. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 176. INDIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 178. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 179. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 180. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 181. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 182. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 183. GERMANY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 185. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 187. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 188. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 189. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 190. UNITED KINGDOM TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 192. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 193. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 194. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 195. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 196. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 197. AUSTRALIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 199. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 201. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 202. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 203. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 204. FRANCE TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 206. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 207. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 208. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 209. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 210. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 211. SOUTH KOREA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 213. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 214. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 215. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 216. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 217. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 218. ITALY TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 220. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 221. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 222. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 223. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 224. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 225. CANADA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 228. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 229. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 230. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 231. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 232. RUSSIA TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 234. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 235. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 236. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 237. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 238. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 239. BRAZIL TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 241. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 242. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 243. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 244. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 245. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 246. MEXICO TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 247. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 248. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 249. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY VALVE MATERIAL, 2018-2032 (USD MILLION)
TABLE 250. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DELIVERY SYSTEM, 2018-2032 (USD MILLION)
TABLE 251. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 252. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY TECHNOLOGY INTEGRATION, 2018-2032 (USD MILLION)
TABLE 253. SPAIN TRANSCATHETER PULMONARY VALVE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The companies featured in this Transcatheter Pulmonary Valve market report include:
  • Abbott Laboratories
  • Artivion Inc.
  • Boston Scientific Corporation
  • Braile Biomedica
  • Edwards Lifesciences Corporation
  • Lepu Medical Technology
  • LivaNova PLC
  • Med-Zenith
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • OrbusNeich Medical Group
  • PolyVascular Inc.
  • Taewoong Medical
  • Terumo Corporation
  • Venus Medtech (Hangzhou) Inc.
  • Xeltis AG

Table Information

Report AttributeDetails
No. of Pages185
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 97.55 Million
Forecasted Market Value ( USD ) by 2032 $ 133.15 Million
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Transcatheter Pulmonary Valves - Global Strategic Business Report - Product Image

Transcatheter Pulmonary Valves - Global Strategic Business Report

  • Report
  • 366 Pages
  • Global
From
Transcatheter Pulmonary Valve Market Size by Technology, Raw Material, Application, End User, and Region 2026-2034 - Product Image

Transcatheter Pulmonary Valve Market Size by Technology, Raw Material, Application, End User, and Region 2026-2034

  • Report
  • 136 Pages
  • Global
From
Transcatheter Pulmonary Valve Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Transcatheter Pulmonary Valve Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 200 Pages
  • Global
From
Transcatheter Pulmonary Valve Market Analysis: Clinical Trends, Technological Segmentation, and Strategic Landscape (2026-2031) - Product Image

Transcatheter Pulmonary Valve Market Analysis: Clinical Trends, Technological Segmentation, and Strategic Landscape (2026-2031)

  • Report
  • 128 Pages
  • Global
From
Transcatheter Heart Valve Market Size, Share & Trends Analysis Report by Application (Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, Transcatheter Mitral Valve), Technology (Self-Expanded, Balloon Expanded) and Region with Growth Forecasts, 2025-2033 - Product Image

Transcatheter Heart Valve Market Size, Share & Trends Analysis Report by Application (Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, Transcatheter Mitral Valve), Technology (Self-Expanded, Balloon Expanded) and Region with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From

About the Market

The Transcatheter Pulmonary Valve (TPV) is a type of cardiovascular device used to treat congenital heart defects. It is a minimally invasive procedure that replaces a damaged pulmonary valve with a new one. The TPV is inserted through a catheter, which is inserted through a vein in the leg and guided to the heart. The procedure is used to treat pulmonary valve stenosis, a condition in which the pulmonary valve does not open properly, leading to a decrease in blood flow to the lungs. The TPV market is a rapidly growing segment of the cardiovascular device market. It is expected to benefit from the increasing prevalence of congenital heart defects, technological advancements, and the growing demand for minimally invasive procedures. The market is also expected to benefit from the increasing number of clinical trials and the growing number of regulatory approvals. Some of the major companies in the Transcatheter Pulmonary Valve market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and St. Jude Medical. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.